Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,250.70
1,228.44
1,111.36
1,110.33
1,068.76
1,062.21
1,011.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,250.70
1,228.44
1,111.36
1,110.33
1,068.76
1,062.21
1,011.17
Raw Material Cost
349.83
307.59
315.94
295.50
284.01
282.22
278.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.97
4.17
7.50
4.88
4.97
4.35
4.01
Selling and Distribution Expenses
583.74
544.31
551.07
477.30
504.06
468.07
439.24
Other Expenses
12.39
11.64
15.84
11.22
11.09
9.25
10.04
Total Expenditure (Excl Depreciation)
1,062.39
972.41
1,032.92
889.90
903.95
847.16
821.80
Operating Profit (PBDIT) excl Other Income
188.29999999999998
256
78.4
220.39999999999998
164.8
215
189.4
Other Income
-9.45
19.53
116.66
35.01
35.71
33.72
50.70
Operating Profit (PBDIT)
255.59
367.98
129.78
349.10
297.74
342.23
153.92
Interest
4.97
4.17
7.50
4.88
4.97
4.35
4.01
Exceptional Items
6.23
3.45
29.05
1.94
2.91
2.82
6.60
Gross Profit (PBDT)
900.87
920.85
795.43
814.83
784.75
779.99
733.04
Depreciation
109.98
109.98
109.79
109.79
108.56
108.56
105.14
Profit Before Tax
146.87
257.28
41.55
236.37
187.13
232.15
51.37
Tax
-22.28
29.65
-56.18
18.06
16.14
25.10
-34.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
161.82
225.27
70.80
215.63
164.75
200.33
91.85
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
161.82
225.27
70.80
215.63
164.75
200.33
91.85
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.83
0.56
-9.41
0.40
7.76
2.53
1.21
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
164.65
225.83
61.39
216.02
172.51
202.86
93.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,566.74
9,148.27
8,933.11
8,772.55
8,538.96
8,918.36
8,712.15
Earnings per share (EPS)
0.15
0.2
0.06
0.19
0.15
0.18
0.08
Diluted Earnings per share
0.15
0.2
0.06
0.19
0.15
0.18
0.08
Operating Profit Margin (Excl OI)
12.4%
19.41%
-8.7%
18.4%
14.36%
18.82%
-0.19%
Gross Profit Margin
20.54%
29.9%
13.62%
31.18%
27.67%
32.08%
15.48%
PAT Margin
12.94%
18.34%
6.37%
19.42%
15.41%
18.86%
9.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 17.02% vs 12.30% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -4.58% vs 17.99% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 1.15% vs 13.96% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 0.00% vs 28.21% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Shenzhen Salubris Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,250.70
0
1,250.70
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,250.70
0
1,250.70
Raw Material Cost
349.83
0
349.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.97
0
4.97
Selling and Distribution Expenses
583.74
0
583.74
Other Expenses
12.39
0.00
12.39
Total Expenditure (Excl Depreciation)
1,062.39
0
1,062.39
Operating Profit (PBDIT) excl Other Income
188.30
0.00
188.30
Other Income
-9.45
0
-9.45
Operating Profit (PBDIT)
255.59
0
255.59
Interest
4.97
0
4.97
Exceptional Items
6.23
0
6.23
Gross Profit (PBDT)
900.87
0
900.87
Depreciation
109.98
0
109.98
Profit Before Tax
146.87
0
146.87
Tax
-22.28
0
-22.28
Provisions and contingencies
0
0
0.00
Profit After Tax
161.82
0
161.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
161.82
0
161.82
Share in Profit of Associates
0
0
0.00
Minority Interest
2.83
0
2.83
Other related items
0.00
0.00
0.00
Consolidated Net Profit
164.65
0
164.65
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,566.74
0
8,566.74
Earnings per share (EPS)
0.15
0
0.15
Diluted Earnings per share
0.15
0
0.15
Operating Profit Margin (Excl OI)
12.40%
0%
0.00
12.40%
Gross Profit Margin
20.54%
0%
0.00
20.54%
PAT Margin
12.94%
0%
0.00
12.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 125.07 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 1.82% vs 10.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 17.02% vs 12.30% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 16.46 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -27.10% vs 267.75% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -4.58% vs 17.99% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.50 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -23.94% vs 2,559.54% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 1.15% vs 13.96% in Jun 2025
Quarterly - Interest
Interest 0.50 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 19.05% vs -44.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs 28.21% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.40%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
